Latest Breaking News On - Douglas losordo - Page 1 : comparemela.com

Cadrenal Therapeutics to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024

PONTE VEDRA, Fla., Jan. 24, 2024 /PRNewswire/ Cadrenal Therapeutics, Inc., , a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant designed to.

Douglas losordoRobert blumMatthew szotJoe pantginisPrnewswire cadrenal therapeutics incCadrenal therapeutics incCompany webcastHc wainwright coLytham partnersChief medical officerManaging directorVitamink antagonist

Cadrenal Therapeutics Expands Evaluation of Tecarfarin for Patients with Antiphospholipid Syndrome (APS)

Cadrenal Therapeutics Expands Evaluation of Tecarfarin for Patients with Antiphospholipid Syndrome (APS)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomDouglas losordoMatthew szotRobert blumCompany annual report on formCadrenal therapeutics incJournal of the american college cardiologyLytham partnersPrnewswire cadrenal therapeutics incHughes syndromeSticky bloodAmerican collegeChief medical officerDirect oral anticoagulantsEnd stage kidney disease

Cadrenal Therapeutics to Participate in the H C Wainwright 25th Annual Global Investment Conference

/PRNewswire/ Cadrenal Therapeutics, Inc., (Nasdaq: CVKD) a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible.

New yorkUnited statesMatthew szotRobert blumDouglas losordoQuang phamLytham partnersLotte new york palace hotelCadrenal therapeutics incPrnewswire cadrenal therapeutics incAnnual global investment conferenceFast trackCadrenal therapeuticsHealth care amp hospitalsMedical pharmaceuticalsTrade show news

Cadrenal Therapeutics to Participate in the H C Wainwright 25th Annual Global Investment Conference

PONTE VEDRA, Fla., Aug. 28, 2023 /PRNewswire/ Cadrenal Therapeutics, Inc., a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant to prevent.

New yorkUnited statesMatthew szotDouglas losordoRobert blumQuang phamCadrenal therapeutics incPrnewswire cadrenal therapeutics incLotte new york palace hotelLytham partnersAnnual global investment conferenceFast track

Cadrenal Therapeutics (CVKD) Provides FY22 Corporate Update

Cadrenal Therapeutics (CVKD) Provides FY22 Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMatthew szotRobert blumDouglas losordoQuang phamCadrenal therapeutics incDrug administrationLytham partnersExchange commissionWall streetFast trackAnnual reportScientific advisory boardChief medical officerChief financialNasdaq capital